HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hartley, C. A. Articles by Studdert, M. J. Search for Related Content PubMed PubMed Citation Articles by Hartley, C. A. Articles by Studdert, M. J. Agricola Articles by Hartley, C. A. Articles by Studdert, M. J.

Equine rhinitis A virus: structural proteins and immune response

Centre for Equine Virology, School of Veterinary Science, The University of Melbourne, Parkville, Victoria 3010, Australia¹
St Vincent’s Institute of Medical Research, 9 Princes Street, Fitzroy, Victoria 3065, Australia²

Author for correspondence: Carol Hartley. Fax +61 3 8344 7374. e-mail carolah{at}unimelb.edu.au

Equine rhinitis A virus (ERAV) is a picornavirus that has been reclassified as a member of the Aphthovirus genus because of its resemblance to foot-and-mouth disease virus at the level of nucleotide sequence and overall genomic structure. The N-terminal amino acid sequence of three of the four capsid proteins of ERAV was determined and showed that the proteolytic cleavage sites within the precursor P1 polypeptide occur exactly as those predicted for an aphthovirus-like 3C protease, which generates the capsid proteins VP1 and VP3. However, the autocatalytic cleavage site between VP4 and VP2, which is independent of 3C protease cleavage, was different from that predicted previously. ERAV.393/76 antisera from horses and rabbits showed different reactivity to the viral structural proteins in both serum neutralization assays and Western blots. High neutralizing antibody titres appeared to correlate with strong reactivity to VP1 in Western blots.

This article has been cited by other articles:

				F. Li, R. A. Stevenson, B. S. Crabb, M. J. Studdert, and C. A. Hartley Several Recombinant Capsid Proteins of Equine Rhinitis A Virus Show Potential as Diagnostic Antigens Clin. Vaccine Immunol., June 1, 2005; 12(6): 778 - 785. [Abstract] [Full Text] [PDF]

				R. A. Stevenson, J.-a. Huang, M. J. Studdert, and C. A. Hartley Sialic acid acts as a receptor for equine rhinitis A virus binding and infection J. Gen. Virol., September 1, 2004; 85(9): 2535 - 2543. [Abstract] [Full Text] [PDF]

				R. A. Stevenson, J.-a. Huang, M. J. Studdert, and C. A. Hartley Identification of a neutralizing epitope in the {beta}E-{beta}F loop of VP1 of equine rhinitis A virus, defined by a neutralization-resistant variant J. Gen. Virol., September 1, 2004; 85(9): 2545 - 2553. [Abstract] [Full Text] [PDF]

				R. A. Stevenson, C. A. Hartley, J.-a. Huang, M. J. Studdert, B. S. Crabb, and S. Warner Mapping epitopes in equine rhinitis A virus VP1 recognized by antibodies elicited in response to infection of the natural host J. Gen. Virol., June 1, 2003; 84(6): 1607 - 1612. [Abstract] [Full Text] [PDF]

				A. Varrasso, H. E. Drummer, J.-a. Huang, R. A. Stevenson, N. Ficorilli, M. J. Studdert, and C. A. Hartley Sequence Conservation and Antigenic Variation of the Structural Proteins of Equine Rhinitis A Virus J. Virol., November 1, 2001; 75(21): 10550 - 10556. [Abstract] [Full Text] [PDF]

				S. Warner, C. A. Hartley, R. A. Stevenson, N. Ficorilli, A. Varrasso, M. J. Studdert, and B. S. Crabb Evidence that Equine Rhinitis A Virus VP1 Is a Target of Neutralizing Antibodies and Participates Directly in Receptor Binding J. Virol., October 1, 2001; 75(19): 9274 - 9281. [Abstract] [Full Text] [PDF]